(UroToday.com) In this talk, Dr. Siamak Daneshman reviewed the prior two abstracts (5006 and 5007) which looked at non-testicular cancer-related deaths in testicular cancer survivors, and clinical features of late relapse disease broken down by chemotherapy exposure and histology, respectively. He first provided his own timeline of major landmarks in germ cell tumor management.
(UroToday.com) Dr. Marvella Elizabeth Ford focused this talk on their social determinants of obesity and its associated risk of certain cancers.
Alicia Morgans: Hi, my name is Alicia Morgans, and I am an Associate Professor of Medicine and a GU Medical Oncologist at Northwestern University in Chicago in the US. I’m so excited to have here with me today a good friend and colleague, Dr. Tom Powles, who is a Professor of Genitourinary Oncology, and the […]
(UroToday.com) Metastatic prostate cancer continues to be driven by androgen signaling, in part through androgen synthesis via CYP17A1 lyase activity. Abiraterone acetate is an FDA-approved inhibitor of CYP17 hydroxylase and lyase activity that has shown clinical benefit when added to chemical castration in advanced prostate cancer but results in mineralocorticoid excess due to inhibition of hydroxylase […]
(UroToday.com) Testicular cancer is the most common cancer in young men, with a very high cure rate largely attributable to the development of cisplatin-based chemotherapy. However, testicular cancer survivors experience excess mortality compared to the general population. To highlight this, she showed the figure below. When focusing on patients diagnosed after 1980, there is a drop-off […]
Over the last four decades, the prevalence of stone disease in the United States has more than tripled from 3.2% in 1980 to 10.1% in 2016.1 A recent study estimated the prevalence of stone disease to be 10.9% in men and 9.5% in women based on data from the National Health and Nutrition Examination Survey […]
(UroToday.com) Curative intent therapy in muscle invasive bladder cancer (MIBC) can be accomplished by either cisplatin-based chemotherapy followed by radical cystectomy, or trimodality bladder preservation therapy via maximal transurethral resection of the bladder tumor (TURBT) followed by chemoradiation. No randomized trials have compared these two options, though propensity risk-matched cohort analyses suggest similar outcomes. Furthermore, the […]
Erectile dysfunction (ED) can negatively affect men’s mental health, interpersonal relationships, and overall well-being. ED has affected >150 million men worldwide, and this number will reach approximately 322 million by 2025.
Background Comparative outcome studies investigating internal Double-J (DJ) and externalized stents have primarily been performed for open and laparoscopic pyeloplasty, with a paucity of literature surrounding outcomes in robotic-assisted laparoscopic pyeloplasty (RALP).
Collagenase clostridium histolyticum (CCH) is a treatment for Peyronie’s disease (PD) whose efficacy and safety has been demonstrated using a classic protocol and a shortened protocol. To evaluate the efficacy and safety of an even more intense protocol in which a CCH injection is applied for 3 separate cycles of 1 week.
